Birtamimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Birtamimab, covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis [Phase 3]